Short-term effects of tolvaptan in individuals with autosomal dominant polycystic kidney disease at various levels of kidney function WE Boertien, E Meijer, PE de Jong, GJ ter Horst, RJ Renken, ... American Journal of Kidney Diseases 65 (6), 833-841, 2015 | 99 | 2015 |
In vitro hemocompatibility testing: The importance of fresh blood SLJ Blok, GE Engels, W van Oeveren Biointerphases 11 (2), 2016 | 51 | 2016 |
Urinary biomarkers to identify autosomal dominant polycystic kidney disease patients with a high likelihood of disease progression AL Messchendorp, E Meijer, WE Boertien, GE Engels, NF Casteleijn, ... Kidney international reports 3 (2), 291-301, 2018 | 46 | 2018 |
Rapid progression of autosomal dominant polycystic kidney disease: urinary biomarkers as predictors AL Messchendorp, E Meijer, FW Visser, GE Engels, P Kappert, ... American journal of nephrology 50 (5), 375-385, 2019 | 35 | 2019 |
Intraoperative cell salvage during cardiac surgery is associated with reduced postoperative lung injury GE Engels, J van Klarenbosch, YJ Gu, W van Oeveren, AJ de Vries Interactive cardiovascular and thoracic surgery 22 (3), 298-304, 2016 | 32 | 2016 |
Urinary EGF receptor ligand excretion in patients with autosomal dominant polycystic kidney disease and response to tolvaptan LR Harskamp, RT Gansevoort, WE Boertien, W van Oeveren, GE Engels, ... Clinical Journal of the American Society of Nephrology 10 (10), 1749-1756, 2015 | 30 | 2015 |
Skin and plasma autofluorescence during hemodialysis: a pilot study R Graaff, S Arsov, B Ramsauer, M Koetsier, N Sundvall, GE Engels, ... Artificial organs 38 (6), 515-518, 2014 | 23 | 2014 |
Biomarkers of lung injury in cardiothoracic surgery GE Engels, W van Oeveren Disease markers 2015, 2015 | 20 | 2015 |
Incidence of massive transfusion and overall transfusion requirements during lung transplantation over a 25-year period V Cernak, AO Lansink-Hartgring, ER van den Heuvel, EAM Verschuuren, ... Journal of cardiothoracic and vascular anesthesia 33 (9), 2478-2486, 2019 | 18 | 2019 |
In vitro blood flow model with physiological wall shear stress for hemocompatibility testing—An example of coronary stent testing GE Engels, SLJ Blok, W van Oeveren Biointerphases 11 (3), 2016 | 18 | 2016 |
The effect of pulsatile cardiopulmonary bypass on lung function in elderly patients GE Engels, M Dodonov, G Rakhorst, W van Oeveren, AD Milano, YJ Gu, ... The International Journal of Artificial Organs 37 (9), 679-687, 2014 | 18 | 2014 |
The utility of lung epithelium specific biomarkers in cardiac surgery: a comparison of biomarker profiles in on-and off-pump coronary bypass surgery GE Engels, YJ Gu, W van Oeveren, G Rakhorst, MA Mariani, ME Erasmus Journal of Cardiothoracic Surgery 8, 1-7, 2013 | 16 | 2013 |
Novel polyurethanes with interconnected porous structure induce in vivo tissue remodeling and accompanied vascularization D Jovanovic, GE Engels, JA Plantinga, M Bruinsma, W Van Oeveren, ... Journal of Biomedical Materials Research Part A 95 (1), 198-208, 2010 | 14 | 2010 |
The effect of vacuum mixing and pre-heating the femoral component on the mechanical properties of the cement mantle M Baleani, E Bialoblocka-Juszczyk, GE Engels, M Viceconti The Journal of Bone & Joint Surgery British Volume 92 (3), 454-460, 2010 | 13 | 2010 |
The optimal incubation time for in vitro hemocompatibility testing: Assessment using polymer reference materials under pulsatile flow with physiological wall shear … SLJ Blok, W van Oeveren, GE Engels Journal of Biomedical Materials Research Part B: Applied Biomaterials 107 (7 …, 2019 | 10 | 2019 |
Comparing changes in plasma and skin autofluorescence in low-flux versus high-flux hemodialysis B Ramsauer, G Engels, S Arsov, H Hadimeri, A Sikole, R Graaff, ... The International Journal of Artificial Organs 38 (9), 488-493, 2015 | 10 | 2015 |
Polyacylurethanes as novel degradable cell carrier materials for tissue engineering D Jovanovic, FV Roukes, A Löber, GE Engels, W Oeveren, XJG Seijen, ... Materials 4 (10), 1705-1727, 2011 | 10 | 2011 |
Skin-and Plasmaautofluorescence in hemodialysis with glucose-free or glucose-containing dialysate B Ramsauer, GE Engels, R Graaff, A Sikole, S Arsov, B Stegmayr Bmc nephrology 18, 1-7, 2017 | 7 | 2017 |
In situ lung perfusion is a valuable tool to assess lungs from donation after circulatory death donors category I–II C Van De Wauwer, AJ Munneke, GE Engels, FM Berga, G Rakhorst, ... Transplant International 26 (5), 485-492, 2013 | 6 | 2013 |
Development of an in vitro system and model-based translational framework to assess haemolysis risk following intravenous abuse of medications containing polyethylene oxide P Persich, GE Engels, W van Oeveren, E Galia, S Benay, S Thun Toxicology in Vitro 65, 104776, 2020 | 3 | 2020 |